Dagmar Schmid | Immunology Cellular Interactions | Women Researcher Award

Published on by Cell Biologist

Dr. Dagmar Schmid | Immunology Cellular Interactions | Women Researcher Award

Dr. Dagmar Schmid, HOCH, Health Ostschweiz, Kantonsspital St.Gallen, Klinik für Psychosomatik und Konsiliarpsychiatrie, Switzerland

PD Dr. med. Dagmar A. Schmid is a German physician and internationally recognized expert in psychosomatic medicine, consultative psychiatry, and sleep research. Born in Neuburg/Donau in 1969, she currently serves as Chief Physician and Director at the Clinic for Psychosomatics, Cantonal Hospital St. Gallen, Switzerland. With over two decades of experience across leading institutions in Germany and Switzerland, Dr. Schmid has made significant contributions to research on chronic pain, sleep disorders, stress, trauma, and Long COVID. Her integrative, evidence-based clinical approach bridges psychotherapy, neuroendocrinology, and psychosomatic care. She is also a passionate educator, holding lectureships at UZH, ETH, HSG, and USB, and is involved in curriculum development for medical training. A Fellow of the Max Planck Society, she holds a habilitation from the University of Zurich. Dr. Schmid combines research leadership, therapeutic innovation, and interdisciplinary collaboration, making her a compelling candidate for the Research for Women Researcher Award.

Publication Profile:

Scopus

✅ Strengths Supporting Suitability for the Award:

1. Outstanding Clinical-Scientific Integration

  • PD Dr. Schmid bridges psychiatry, psychosomatics, sleep medicine, and trauma, integrating clinical practice with impactful research.

  • Her work is deeply translational, evidenced by studies like CBT for narcolepsy, multimodal pain therapy, and psychotraumatology in somatic settings.

2. Highly Relevant and Timely Research Topics

  • Research on Long COVID, psychotraumatology, insomnia, and workplace mental health is at the forefront of global health challenges.

  • Interdisciplinary projects (e.g., with neurology, gynecology, immunology) reflect innovation and relevance to both women’s and public health.

3. International Recognition & Academic Output

  • Over 40 peer-reviewed publications, including in high-impact journals.

  • Multiple first-author papers, invited talks, and poster awards reflect peer validation.

  • Recipient of prestigious awards and fellowships (e.g., Max Planck Society, Heraeus Foundation).

4. Leadership and Mentorship

  • Clinic Director and Chief Physician since 2017.

  • Responsible for establishing therapy units and sleep diagnostics services.

  • Supervises dissertations, reflecting her mentorship commitment, especially valuable for empowering future women researchers.

5. Teaching & Outreach

  • Teaching roles at major Swiss institutions (ETH, UZH, HSG, USB).

  • Leadership in educational modules on psychosomatics, communication, and sleep disorders.

  • Speaker in national specialist curricula, enhancing knowledge dissemination.

6. Focus on Women’s Health

  • Specific projects on gynecological trauma, psychosomatics in oncology, and stress-related conditions affecting women’s mental and physical health.

⚠️ Areas for Potential Improvement or Future Growth:

1. International Visibility in Gender-Specific Medicine

  • While her research is highly relevant to women’s mental health, more direct engagement in gender-specific medical research networks or global women’s health collaborations would further strengthen her candidacy.

2. Research Leadership in Consortia

  • Leading international multicenter studies or EU-funded programs would enhance her influence on policy-level decisions in women’s mental health.

3. Visibility in Advocacy and Policy

  • Greater participation in public policy or healthcare advisory roles (e.g., for WHO or national bodies) on topics like Long COVID in women or trauma-informed care would expand her societal impact.

🎓 Education:

Dr. Schmid earned her medical doctorate at the Max Planck Institute of Psychiatry, Munich, with a dissertation on hormone secretion and sleep EEG in depression. From 1998 to 2002, she held a prestigious scholarship from the Max Planck Society, further advancing her research in psychoneuroendocrinology. Her habilitation (postdoctoral qualification) was completed at the University of Zurich in 2023, titled “Psychophysiology in Psychosomatics Using Sleep as an Example”. She is a certified specialist in psychiatry and psychotherapy in both Germany and Switzerland. Her therapeutic training includes Cognitive Behavioral Therapy (CBT), Dialectical Behavioral Therapy (DBT), Interpersonal Psychotherapy (IPT), EMDR trauma therapy, hypnotherapy, and CBASP for chronic depression. Dr. Schmid has also completed the GCP clinical research certification, the SIM expert certificate, and advanced training in psycho-oncology. Her interdisciplinary education forms the foundation of her clinical innovation and scientific impact.

💼 Professional Experience:

Dr. Schmid has held senior positions in top psychiatric and psychosomatic institutions. From 1998–2002, she worked at the Max Planck Institute, followed by clinical roles in Zurich and Basel. At Clienia Schlössli AG, she led psychotherapy and DBT programs, later joining the University Hospital Zurich, working in sleep medicine, liaison psychiatry, and emergency psychiatry. Since 2017, she is Chief Physician and Clinic Director for Psychosomatics and Consultant Psychiatry at the Cantonal Hospital St. Gallen, where she also established a sleep diagnostics department. She’s active in training and supervising medical staff, conducting expert evaluations, and coordinating interdisciplinary care for Long COVID, trauma, and chronic pain. Since 2025, she has also been affiliated with the University Hospital Basel. Her professional journey reflects leadership in clinical development, patient-centered innovations, and academic collaboration.

🏆 Awards & Honors:

Dr. Schmid’s excellence in research and clinical work has been recognized with multiple awards. She received the prestigious Max Planck Society Fellowship (1998–2001) and the Heraeus Foundation Award in 2000. She has won poster prizes at national congresses for work in psychotraumatology (SAPPM/SPS 2022) and sleep-pain therapy (SGPP 2022). She holds the Certificate of Competence in Sleep Medicine, Psycho-Oncology, and is a certified CBT/DBT/IPT/EMDR therapist. She’s a frequent speaker in consultant psychiatry and psychosomatics curricula across Switzerland and Germany, and has led training programs for medical communication, CBT-insomnia, and trauma therapy. Her habilitation (2023) and over 40 peer-reviewed publications reflect sustained academic achievement. Additionally, she has supervised doctoral and master’s theses and collaborated in major clinical research projects, including Long COVID, narcolepsy, and psychosomatic gynecology. These honors and contributions underscore her qualification for the Research for Women Researcher Award.

🔬 Research Focus:

Dr. Schmid’s research bridges psychosomatic medicine, neuroendocrinology, and sleep science, with emphasis on chronic pain, trauma, stress disorders, and Long COVID. Her work explores how hormonal rhythms, sleep patterns, and mental health interact—using sleep EEG, endocrine markers, and clinical interventions. She developed novel group therapies for narcolepsy, dizziness, and insomnia and led outcome evaluations for interdisciplinary multimodal pain therapy (IMPT). Her recent focus includes psychosocial recovery in healthcare workers post-COVID, and pilot studies on plasmapheresis in chronic fatigue syndrome. She also investigates cognitive outcomes, emotion regulation, and therapeutic online models, especially for vulnerable populations. Her research integrates clinical trials, neurobiology, and psychotherapy, contributing to evidence-based advancements in psychosomatic practice. She leads projects at the Cantonal Hospital St. Gallen and collaborates with researchers across neurology, gynecology, and internal medicine, making her research highly interdisciplinary and translational in nature.

📚 Publications Top Notes:

  • 🧠 Increased GH Response to Apomorphine in Parkinson vs MSA (Arch Neurol, 2001)

  • 🍔 Ghrelin Stimulates Appetite, GH, ACTH, Cortisol in Normals (Sleep Res, 2005)

  • 🛌 Nocturnal Ghrelin Levels & Sleep EEG Correlation (Psychoneuroendocrinology, 2006)

  • 🌙 CRH1-Antagonist Improves Sleep EEG in Depression (J Psychiatr Res, 2004)

  • 🌀 Dizziness and Anxiety – A Psychosomatic Link (Health Qual Life Outcomes, 2020)

  • 😴 Ghrelin Promotes Deep Sleep in Humans (AJPEM, 2003)

  • 🧬 CRH Test, Sleep, and Depression Vulnerability (J Psychiatr Res, 2008)

  • 🧪 Cortisol and Sleep Depth in Depression (J Psychiatr Res, 2008)

  • 🦠 HPA Axis & Cytokines in Depression (J Psychiatr Res, 2003)

  • 🧬 Factors Affecting HPA Reactivity in Depression (Neuropsychopharmacology, 2003)

  • 🧘‍♀️ Long COVID & Mental Health in Healthcare Workers (In Prep, 2025)

  • 🛏 IMPT Effectiveness in Chronic Pain-Related Insomnia (In Progress)

  • 🎯 Group Therapy in Narcolepsy: Emotion Regulation & Acceptance (2021-2022)

  • 🎓 CBT-Insomnia Education for Non-Psychiatrists (Ongoing Teaching)

✅ Conclusion:

PD Dr. med. Dagmar A. Schmid is an exceptionally qualified and impactful candidate for the Research for Women Researcher Award. Her integrative, patient-centered research, particularly in sleep medicine, psychotraumatology, and Long COVID, directly contributes to improving women’s health. Combined with her extensive clinical leadership, educational outreach, and publication record, she exemplifies the spirit of this award.

Xiaoyan Wang | Immunology Cellular Interactions | Best Paper Award

Published on by Cell Biologist

Ms. Xiaoyan Wang | Immunology Cellular Interactions | Best Paper Award

Ms. Xiaoyan Wang | Fudan University | China

Dr. Xiaoyan Wang is a dedicated cardiologist and postdoctoral fellow at Fudan University with a strong background in both clinical practice and cardiovascular research. With over a decade of academic training and medical experience, she has built expertise in ventricular remodeling, percutaneous coronary interventions, and immune responses in heart diseases. Under the mentorship of esteemed scholars such as Dr. Yunzeng Zou and Academician Yaling Han, she has published extensively in high-impact journals, reflecting her commitment to scientific advancement. Dr. Wang is currently a scholar in Harvard Medical School’s Global Clinical Scholars Research Training program and also serves as a section editor for the AME Clinical Trials Review. She actively contributes to academic communities, notably by organizing the “Excellent Academic Research Communication Club.” Her work bridges translational medicine and clinical application, aiming to improve cardiovascular patient outcomes through innovative, evidence-based approaches.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Outstanding Academic Credentials: Dr. Wang has earned her PhD from the prestigious Fudan University and is currently in the Harvard Medical School’s Global Clinical Scholars Research Training Program, signaling a top-tier academic and global research profile.

  2. Dual Research Strength in Basic and Clinical Sciences: She demonstrates an exceptional ability to bridge molecular mechanisms (e.g., immune pathways, cGAS-STING, miRNAs, circular RNAs) with clinical relevance (e.g., myocardial infarction prognosis, anemia impact in PCI), making her work highly translational.

  3. High-Impact Publications: First-author or co-first-author in peer-reviewed journals such as Signal Transduction and Targeted Therapy, Angiology, and Frontiers in Cardiovascular Medicine, with publications tackling cutting-edge cardiovascular topics.

  4. Collaborative and Interdisciplinary Focus: Contributions across institutions and disciplines—partnering with bioinformaticians, clinicians, and molecular scientists—demonstrate strong collaboration skills.

  5. Recognition & Editorial Role: Multiple awards (CPSF Fellowship, Super Postdoc at Fudan) and an editorial position at AME Clinical Trials Review show leadership and peer acknowledgment.

🛠️ Areas for Improvement:

  1. More First-Author Lead on Recent Papers: Although she holds strong co-first authorships and collaborative contributions, maintaining or increasing sole first-author outputs on impactful papers would further strengthen individual scholarly identity.

  2. Increased International Conference Visibility: While she has presented at JCS, continued or expanded visibility in global cardiovascular congresses (e.g., AHA, ESC, ACC) would enhance recognition.

  3. Grant Leadership: Future grant applications as a principal investigator (rather than team member) could affirm her leadership in project design and execution.

🎓 Education :

Dr. Xiaoyan Wang holds a Ph.D. from Fudan University’s Zhongshan Hospital (2016–2019), where she conducted fundamental research on ventricular remodeling under Dr. Yunzeng Zou’s mentorship, supported by prestigious national fellowships. She earned her Master’s degree from Dalian Medical University (2013–2016), focusing on clinical research in percutaneous coronary intervention, under Academician Yaling Han. Her academic foundation was laid with a Bachelor’s degree in Medicine from Fujian Medical University (2007–2012). Currently, she is advancing her research and clinical skills in the prestigious Global Clinical Scholars Research Training Program at Harvard Medical School (2024–2025), blending in-person and online modules. Her multi-tiered education reflects a deep integration of basic science, translational medicine, and clinical practice in cardiovascular health, equipping her to lead high-impact research and patient care initiatives.

💼 Experience:

Dr. Wang is currently a Postdoctoral Fellow at Fudan University (since 09/2023), working under Prof. Yunzeng Zou. She is also the organizer of the Excellent Academic Research Communication Club, promoting interdisciplinary dialogue. From 07/2022 to 07/2023, she served as a cardiologist at Shanghai Jiaotong University’s Ruijin Hospital, and from 2019 to 2022, as a resident in internal medicine at Zhongshan Hospital. In 2024, she began contributing as a section editor for AME Clinical Trials Review, enhancing the quality and visibility of clinical trial research. Her experience spans clinical cardiology, postdoctoral research, editorial responsibilities, and academic leadership. These roles have solidified her ability to translate scientific knowledge into medical practice, particularly in the cardiovascular field.

🏆 Awards & Honors:

Dr. Wang has received numerous accolades recognizing her academic excellence and research impact. In 2023, she was awarded both the Postdoctoral Fellowship Program of the China Postdoctoral Science Foundation (CPSF) and the prestigious Super Postdoctoral Fellowship of Fudan University, underscoring her leadership in postdoctoral research. Her communication and writing skills were acknowledged with the Third Prize in the 8th “Buchang Cup” Young Physician Essay Contest (2019). She also presented Late Breaking Cohort Studies at the Japanese Circulation Society (JCS) Annual Meeting 2019, reflecting international recognition of her scientific contributions. These honors reflect her potential as a rising leader in cardiovascular medicine and support her suitability for the Best Paper Award.

🔬 Research Focus :

Dr. Wang’s research focuses on cardiovascular disease mechanisms, particularly immune system regulation, ventricular remodeling, and the molecular basis of heart failure. Her Ph.D. and postdoctoral studies have addressed the cGAS-STING pathway, miRNA biomarkers, circular RNAs, and inflammation-related signaling in cardiovascular dysfunction. She has also explored clinical prognostic models, such as CHA2DS2-VASc scoring, and interventions including left atrial appendage occlusion and shock wave therapy for ischemic cardiomyopathy. Her dual interest in basic science and clinical outcomes allows her to design translational research that bridges laboratory findings and therapeutic advancements. With a strong publication record and ongoing involvement in global research training at Harvard Medical School, her work aims to inform precision medicine strategies in cardiology.

📚 Publication Titles Top Notes:

  1. 🧠 The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications

  2. 🔗 The connection of immune response and cGAS-STING pathway in cardiovascular disease

  3. 🐭 Left ventricular response in hypertrophy-to-failure transition: roles of Akt, β-arrestin-2, and CaMKII

  4. 💉 Circulating miRNAs in hypertension: diagnostic value and bioinformatics analysis

  5. 🧪 Galectin-3 inhibition improves endothelial progenitor function via autophagy suppression

  6. 🔄 Circular RNA in cardiovascular disease

📌 Conclusion:

Dr. Xiaoyan Wang is highly suitable for the Research for Best Paper Award. Her profile reflects a rare and valuable integration of basic cardiovascular science and clinical innovation, with high-impact, well-cited publications and ongoing international training. Her trajectory, marked by excellence, discipline, and collaborative leadership, meets and exceeds the criteria for this award.

An Dai Tran | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Mr. An Dai Tran | Immunology Cellular Interactions | Best Researcher Award

Mr. An Dai Tran, Walailak University, Vietnam

Dr. An Dai Tran is a dedicated medical doctor and emerging public health researcher from Vietnam, currently pursuing a Master’s degree at Walailak University, Thailand. He works at the CDC Dong Thap, focusing on vaccination programs and infectious disease control, including dengue fever, COVID-19, and measles. With several years of hands-on experience in clinical trials and epidemiological research, Dr. Tran has made significant contributions to community health. His published work on vaccination adherence among minority groups in Vietnam has had real-world impact on public health campaigns. Additionally, he has co-developed innovative tools for behavioral science and contributed to machine learning applications in mental health. Collaborating with global institutions such as the University of Queensland and the Pasteur Institute, Dr. Tran’s work reflects a commitment to translational research, public health equity, and data-driven health interventions. His profile is marked by scientific rigor, international collaboration, and service to underserved populations.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Interdisciplinary Research Excellence
    Dr. Tran’s research spans infectious diseases, vaccination behavior, and digital mental health—demonstrating versatility and innovation in addressing modern public health challenges.

  2. Practical and Policy-Relevant Impact
    His work on vaccination adherence in minority communities has real-world implications for national health policy and outreach programs, especially in underserved populations.

  3. Strong Clinical Trial Experience
    He has held critical roles in major vaccine trials (COVID-19 and hand-foot-mouth disease), showing competence in trial design, blinding, and coordination—essential for translational health research.

  4. Collaborative Global Network
    Dr. Tran has established collaborations with renowned institutions such as the University of Queensland and the Pasteur Institute, boosting the credibility and scalability of his research.

  5. Innovation in Mental Health Analytics
    His application of AI and machine learning to post-COVID mental health challenges shows forward-thinking research methodology with future potential.

  6. Published and Cited
    With publications in peer-reviewed journals like Jornal de Pediatria and Journal of Human, Earth, and Future, and a growing citation index, he is building a solid academic foundation.

🛠️ Areas for Improvement:

  1. Broader Indexing and Citations
    While promising, most of his current publications are in emerging or interdisciplinary journals. Publishing in higher-impact, SCI-indexed journals could enhance academic visibility.

  2. Editorial and Peer Review Roles
    Taking on editorial appointments or peer-review duties would strengthen his professional profile and leadership in research.

  3. Mentorship and Teaching Contribution
    Engaging in formal mentorship or academic teaching roles would reflect his potential as a knowledge disseminator and academic influencer.

  4. Expanded Public Health Policy Impact
    Future work that integrates direct contributions to policy development or national programs would further validate his applied research strengths.

🎓 Education:

Dr. An Dai Tran holds a medical degree and is currently completing a Master’s in Public Health at the School of Public Health, Walailak University, Thailand. He was awarded a full scholarship for his postgraduate studies in recognition of his academic excellence and commitment to public health. His education bridges clinical medicine with population-level health sciences, equipping him with multidisciplinary expertise to tackle emerging global health challenges. At Walailak University, Dr. Tran has deepened his knowledge in epidemiology, biostatistics, global health policy, and digital health technologies. His academic training is complemented by a strong foundation in research methodology and ethics, allowing him to conduct high-impact studies and clinical trials. His exposure to both theoretical and practical facets of public health, along with mentorship from international experts, positions him as a future leader in healthcare innovation, with special focus on vaccine-preventable diseases and mental health research in Southeast Asia.

💼 Professional Experience:

Dr. Tran brings valuable on-ground experience through his work at the CDC Dong Thap in Vietnam, where he has led and supported various national vaccination campaigns and infectious disease monitoring systems. He has been actively involved in both the operational and research aspects of public health interventions. His clinical trial roles include coordinating blinded and double-blinded studies on COVID-19 and hand-foot-mouth vaccines. Notably, he served as a research coordinator in large-scale, placebo-controlled trials with rigorous ethical and methodological frameworks. His consultancy record includes four projects in collaboration with governmental and academic institutions, such as the University of Queensland (E-Dengue Project) and the Pasteur Institute (Vietnam-based vaccine research). Dr. Tran’s experience spans public health research, disease surveillance, behavioral analysis, and machine learning for mental health prediction. His combined roles as physician, coordinator, and academic researcher highlight his versatility, responsibility, and drive for impactful health innovations that reach marginalized communities.

🧠 Research Focus:

Dr. Tran’s research lies at the intersection of infectious diseases, vaccination behavior, and digital mental health. His primary interest is understanding the behavioral and sociocultural factors affecting vaccine uptake, particularly among ethnic minority populations. His first-author publication on this topic has already contributed to improved regional strategies for vaccine delivery. Expanding into digital health, Dr. Tran has co-developed psychological assessment tools and applied machine learning to detect mental health issues in post-COVID patients. His work in computational psychiatry includes Reddit-based community sentiment analysis and comparative modeling for long COVID mental health prediction. By merging AI with public health, he aims to enhance early detection and intervention systems. His approach reflects a holistic vision—bridging clinical practice, community outreach, and technology—with a commitment to healthcare equity. Dr. Tran’s research is not only academically sound but also practically applicable, aligning with Sustainable Development Goals (SDGs) for health and well-being.

📚 Publications Top Notes:

  1. 🧬 Parental predictors of childhood vaccination adherence in border areas of Southern Vietnam – Jornal de Pediatria.

  2. 🏃‍♂️ Initial Construction of the Exercise Maintenance Motivation Scale: A Mixed Method Study – Journal of Human, Earth, and Future.

  3. 🤖 An Analysis of Machine Learning for Detecting Depression, Anxiety, and Stress of Recovered COVID-19 Patients – Journal of Human, Earth, and Future.

  4. 🧠 Exploring Mental Stress Expressions in Online Communities: A Subreddit Analysis – Journal of Human, Earth, and Future.

  5. 🧪 Mental health and long COVID status prediction among recovered COVID-19 patients: A comparison of machine learning methods – Journal of Human, Earth, and Future.

🧾 Conclusion:

Dr. An Dai Tran is a highly promising early-career researcher whose interdisciplinary work in public health is both scientifically rigorous and socially impactful. His blend of clinical trial expertise, digital health innovation, and public health behavior research makes him an ideal candidate for the Best Researcher Award. While there is room to grow in areas like journal prestige and academic leadership, his current trajectory, achievements, and commitment to health equity clearly demonstrate award-worthy excellence.

Yidong Wei | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Prof. Yidong Wei | Immunology Cellular Interactions | Best Researcher Award

Prof. Yidong Wei , Shanghai Tenth People’s Hospital, Tongji University , China

Dr. Yidong Wei, M.D., Ph.D., FACC, is a distinguished professor and the Chief of Cardiology at Shanghai Tenth People’s Hospital, Tongji University. He also holds a clinician management role at the Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford. With a strong foundation in both clinical and translational research, Dr. Wei has built an internationally recognized career focused on interventional cardiology, cardiac electrophysiology, and cardiovascular epidemiology. He is a Fellow of the American College of Cardiology, reflecting his global academic influence. Known for bridging clinical care with bench-side discovery, his work has advanced understanding in myocardial infarction, heart failure, and calcium signaling in cardiomyocytes. With numerous high-impact publications and leadership in multicenter registries like NOAFCAMI-SH, Dr. Wei’s contributions are widely cited and clinically relevant. His dual academic and clinical roles across China and the UK highlight his dedication to innovation, international collaboration, and excellence in cardiovascular medicine.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. High-Impact Research Output:
    Dr. Wei has authored or co-authored more than 18 recent peer-reviewed publications in prestigious journals such as Diabetes Metabolism Research and Reviews, Redox Biology, Cardiovascular Diabetology, and ESC Heart Failure. Many of these works are already cited, indicating early academic impact and relevance.

  2. Dual Focus – Basic and Clinical Science:
    His research bridges the gap between molecular mechanisms (e.g., calcium signaling, TRIM21, PTEN) and clinical cardiology (e.g., atrial fibrillation, myocardial infarction, cardiac remodeling), highlighting a robust translational focus.

  3. Leadership and Collaboration:
    He serves as Chief of Cardiology at Shanghai Tenth People’s Hospital and a Clinician Manager at the University of Oxford, demonstrating international leadership and cross-border collaboration.

  4. Registry Leadership (NOAFCAMI-SH):
    His work through the NOAFCAMI-SH registry provides real-world evidence on cardiovascular disease progression, risk prediction, and treatment response—critical for patient-centered care.

  5. Prestigious Recognition:
    Dr. Wei is a Fellow of the American College of Cardiology (FACC), a title reserved for top-tier cardiovascular professionals with sustained excellence.

⚠️ Areas for Improvement:

  1. Broader International Research Leadership:
    While Dr. Wei has strong China–UK collaborations, leading global multicenter clinical trials or international consortia would further solidify his standing.

  2. Public Engagement and Knowledge Translation:
    Though academically prolific, increased involvement in public health education or policy advocacy could amplify the real-world impact of his research.

  3. Mentorship Track Record Visibility:
    Highlighting mentorship of junior researchers and postdocs more explicitly in profiles and bios would enhance his case for a holistic academic leadership award.

🎓 Education:

Dr. Wei began his medical education at Henan Medical University, where he completed clinical training with a focus on cardiovascular medicine. Driven by a passion for research, he pursued and completed his Ph.D. in 2004, with a specialization in cardiac electrophysiology and calcium signaling pathways. His graduate studies were complemented by advanced basic science training at the University of Kentucky, USA, a leading institution in biomedical research. Between 2004 and 2006, Dr. Wei completed postdoctoral research, focusing on the molecular mechanisms of cardiac dysfunction and electrophysiology. His educational background reflects a balanced integration of rigorous clinical education and innovative research development, equipping him with the tools necessary to bridge bedside care with laboratory insights. This foundation has allowed Dr. Wei to contribute to both academic medicine and cutting-edge cardiovascular research, distinguishing him as a leader with comprehensive and global training in the field.

🏥 Experience:

With over two decades of experience, Dr. Yidong Wei serves as Professor and Chief of the Department of Cardiology at Shanghai Tenth People’s Hospital, Tongji University. His role extends internationally, acting as Clinician Manager at the University of Oxford’s Centre for Diabetes, Endocrinology and Metabolism. His clinical expertise spans interventional cardiology, acute coronary syndromes, and electrophysiological interventions, while his research roles emphasize trial design, biomarker discovery, and cellular cardiology. He has led and contributed to large-scale registries like NOAFCAMI-SH, generating evidence that informs guidelines for myocardial infarction and atrial fibrillation. His professional experience combines healthcare leadership, cross-border academic collaboration, and impactful research. As a Fellow of the American College of Cardiology, he is actively engaged in academic societies and peer-reviewed journals. Dr. Wei’s experience reflects an enduring commitment to patient care, innovation in research, and mentorship of future cardiology leaders, marking him as a high-impact contributor in his field.

🔬 Research Focus:

Dr. Yidong Wei’s research lies at the intersection of clinical cardiology and molecular medicine. He focuses on interventional cardiology, atrial fibrillation, myocardial infarction, and calcium signaling pathways in cardiac myocytes. A major theme in his work is the electrophysiological basis of heart failure and age-related changes in ventricular function. Using techniques like patch clamping, calcium imaging, laser confocal microscopy, and molecular biology, he investigates calcium channel regulation and excitation-contraction coupling in cardiac cells. Clinically, he leads research through the NOAFCAMI-SH registry, analyzing systemic inflammation, hyperglycemia, atrial fibrillation, and long-term cardiac outcomes. His work advances the understanding of post-infarction remodeling and atrial pathology. Combining basic science with real-world data, Dr. Wei’s research bridges gaps in translational cardiology and offers therapeutic targets for chronic cardiac conditions. His integrative approach makes him a pioneer in translating bench findings into bedside impact, with potential to redefine cardiac care strategies globally.

📚 Publications Top Notes:

  1. 📈 Association of stress hyperglycemia ratio with atrial fibrillation and outcomes in myocardial infarction

  2. 🧪 Prognostic implications of systemic immune-inflammation index in MI patients with and without diabetes

  3. 🧬 TRIM21 deficiency protects heart post-MI by reducing oxidative stress

  4. 🫀 4S-AF scheme for characterizing atrial fibrillation after myocardial infarction

  5. 🔬 TRIM21 worsens cardiac injury via M1 macrophage polarization post-MI

  6. 🧮 Stress hyperglycemia and outcomes in MI with and without diabetes mellitus

  7. 💉 ZPI protects endothelium via PI3K/Akt pathway activation against ox-LDL

  8. 📊 Atrial fibrillation’s prognosis across heart failure subtypes post-MI

  9. 🕒 Five-year outcomes post left atrial appendage occlusion

  10. 🧫 PTEN and serum deprivation-induced cytotoxicity via PI3K/AKT pathway

🧾 Conclusion:

Dr. Yidong Wei stands out as a highly suitable candidate for the Best Researcher Award. His contributions to cardiovascular research—spanning cutting-edge basic science to influential clinical trials—are both innovative and impactful. His leadership roles, international presence, and translational focus align perfectly with the goals of this prestigious recognition. Given his trajectory, Dr. Wei is not only a leader in current cardiovascular research but also a driver of future scientific breakthroughs.

Ahmet Kor | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Ahmet Kor | Immunology Cellular Interactions | Best Researcher Award

Assoc. Prof. Dr. Ahmet Kor , aksaray university training and research hospital , Turkey

Dr. Ahmet Kor is an associate professor at the Department of Rheumatology, Aksaray Education and Research Hospital, Turkey. With a profound expertise in rheumatology, he has made significant contributions to biomarker-based research in various rheumatological diseases. Dr. Kor is well-known for his pioneering work in understanding the relationship between rheumatoid arthritis (RA) and interstitial lung disease, as well as his research on small vessel vasculitis and renal estrogen receptors. His work is highly regarded for its originality and depth in the study of biomarkers and disease mechanisms. Dr. Kor’s academic journey has seen him publish numerous journal articles, collaborate with global researchers, and gain recognition in the field. He is committed to advancing rheumatology research and improving clinical outcomes for patients with autoimmune diseases.

Publication Profile:

Orcid

Strengths for the Award:

Dr. Ahmet Kor’s impressive body of work in rheumatology, particularly his focus on biomarkers, places him as an ideal candidate for the “Best Researcher Award.” He has contributed significantly to understanding complex mechanisms in autoimmune diseases such as rheumatoid arthritis (RA) and primary Sjögren’s syndrome. Notably, his pioneering research into the relationship between RA and interstitial lung disease, as well as his exploration of estrogen receptors in small vessel vasculitis, has opened new avenues for diagnostics and treatment. With a remarkable publication record, Dr. Kor has demonstrated both depth and breadth in his research, having published 17 peer-reviewed articles in SCI-indexed journals. His research also bridges the gap between clinical practice and scientific exploration, which enhances its relevance. His ability to identify novel biomarkers like netrin-1 in various diseases showcases his innovative thinking and commitment to advancing rheumatology.

Areas for Improvements:

While Dr. Kor’s research is highly impactful, expanding the focus of his work to include larger-scale clinical trials could provide additional validation of his findings in broader populations. Furthermore, enhancing collaborations with research institutions worldwide could increase the global applicability of his discoveries. A more extensive exploration into therapeutic implications of his findings may also contribute significantly to clinical advancements.

Education:

Dr. Ahmet Kor completed his medical degree (MD) at a prestigious university in Turkey, focusing on the field of rheumatology. He then pursued specialized training and completed his residency in internal medicine before further refining his expertise in rheumatology. His educational background allowed him to develop a deep understanding of autoimmune diseases, particularly their biomarkers and disease progression. Throughout his academic career, Dr. Kor has engaged in continuous education and research, publishing books and numerous peer-reviewed journal articles. His research interests have evolved into studying the molecular mechanisms underlying rheumatological diseases, contributing valuable knowledge to both the academic and clinical communities. Dr. Kor’s educational foundation combined with his professional training has solidified his status as a leading expert in rheumatology, and he continues to inspire students and colleagues alike through his work and teachings.

Experience:

Dr. Ahmet Kor has significant experience in both clinical practice and academic research in rheumatology. He currently holds the position of associate professor at Aksaray Education and Research Hospital in Turkey, where he leads a team of researchers in exploring biomarker-based studies for rheumatological diseases. Over the years, Dr. Kor has worked extensively in clinical settings, diagnosing and treating various autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus, and small vessel vasculitis. His extensive research portfolio spans multiple domains, from interstitial lung diseases to novel biomarkers for autoimmune diseases. Dr. Kor has been involved in consulting for the pharmaceutical industry and collaborated with other research institutions globally. His experience extends beyond clinical practice, as he actively contributes to scientific journals, editorial roles, and academic committees. His ability to bridge research with clinical application allows him to make lasting contributions to the field of rheumatology.

Research Focus:

Dr. Ahmet Kor’s research focuses on the exploration of biomarkers in rheumatology, particularly in autoimmune diseases such as rheumatoid arthritis (RA) and small vessel vasculitis. His work aims to identify novel biomarkers that can predict disease progression, diagnose early-stage diseases, and guide therapeutic interventions. He has made significant discoveries regarding the relationship between RA-associated interstitial lung disease and netrin-1 levels, as well as the connection between small vessel vasculitis and renal estrogen receptors. Additionally, Dr. Kor’s research delves into the molecular mechanisms of disease, such as the thiol/disulfide balance in psoriatic arthritis and the potential role of estrogen receptors in primary Sjögren’s syndrome. His studies are instrumental in advancing personalized medicine in rheumatology, with the aim of improving diagnostic accuracy and therapeutic outcomes. Through his interdisciplinary research, Dr. Kor seeks to make impactful contributions to the understanding of autoimmune diseases and their biomarkers.

Publications Top Notes:

  • Urinary Total Superoxide Dismutase Activity in Rheumatoid Patients 🔬🧬

  • Does Eta Protein Differentiate Rheumatoid Arthritis from Psoriatic Arthritis? 🤔💉

  • Renal Tubular Estrogen ß Receptors in Small Vessel Vasculitis 🧑‍🔬🔬

  • Thiol/Disulfide Balance in Psoriatic Arthritis 🧪🧬

  • Ensemble Learning and Feature Selection in Diagnosis of Low Back Pain 💻🩺

  • Serum Netrin-1 Level in Rheumatoid Arthritis 🧪🔬

  • Estrogen Receptor ß in Minor Salivary Glands of Primary Sjögren’s Syndrome 🧑‍🔬💉

  • Serum Netrin-1 as a Potential Biomarker for Diabetic Peripheral Artery Disease 🩸💉

  • 14-3-3η Proteins in Primary Sjögren Syndrome 🧬💡

Conclusion:

Dr. Ahmet Kor is a distinguished researcher whose contributions to the field of rheumatology, particularly in biomarker-based studies, make him highly deserving of the “Best Researcher Award.” His innovative approach to understanding complex autoimmune diseases, combined with his extensive publications and collaborations, reflects his dedication to improving patient care and advancing the scientific understanding of rheumatology. His research offers significant potential for future breakthroughs, making him an outstanding candidate for this prestigious award.

Dia Aldeen Alfaki | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Mr. Dia Aldeen Alfaki | Immunology Cellular Interactions | Best Researcher Award

Mr. Dia Aldeen Alfaki , Alzaiem Alazhari University , Sudan

Dia Alfaki is a Sudanese biomedical scientist with a Master of Biomedical Sciences and extensive experience in haematology, molecular biology, and immunology. His research focuses on the complexities of disease mechanisms and therapeutic solutions, particularly within immunology. As a junior researcher and PG Member of the British Society of Immunology, Dia has contributed significantly to studies on malaria and immune responses. His academic background includes a Master’s degree from Alzaiem Alazhari University and a Bachelor’s degree from Omdurman Islamic University. Dia’s dedication to understanding disease complexities through research is reflected in his growing academic presence and expertise in clinical laboratory techniques. He is committed to advancing scientific knowledge and improving healthcare solutions through his research endeavors.

Publication Profile: 

Orcid

Strengths for the Award:

Dia Alfaki has a remarkable blend of educational qualifications, practical experience, and academic research, making him highly suitable for the Research for Best Researcher Award. His work spans critical areas in biomedical sciences, with a special focus on immunology, haematology, and molecular biology, especially in relation to infectious diseases like malaria. His Master’s research on immune responses to Plasmodium falciparum infection stands out, demonstrating his ability to identify novel immunological markers. His published work in well-regarded journals like Microbiologia Medica and Immunology & Cell Biology further showcases his expertise. He has actively contributed to the scientific community through various international conferences, highlighting his commitment to advancing research. His work at G42 Healthcare underscores his technical skills in molecular diagnostics and cutting-edge biomedical research. His collaborative nature, critical thinking, and proven leadership in research make him a strong contender for this award.

Areas for Improvement:

While Dia Alfaki has a solid foundation in immunology and biomedical research, further expansion of his research portfolio into diverse therapeutic fields could enhance his profile. Gaining more experience in clinical settings beyond molecular labs could provide him with a broader perspective in healthcare applications. Additionally, his involvement in multi-disciplinary research collaborations across diverse disease areas such as oncology and genomics would elevate his impact on global biomedical challenges. Developing greater expertise in bioinformatics tools and integrating them into his molecular research would further refine his analytical skills and position him as an even more influential scientist in his field.

Education:

Dia Alfaki holds a Master’s degree in Biomedical Sciences from Alzaiem Alazhari University (2014-2016), where he specialized in Medical Laboratory Sciences with a focus on Haematology and Blood Transfusion, achieving a CGPA of 3.19/4.0. He completed his Bachelor’s degree in Medical Laboratory Sciences from Omdurman Islamic University (2007-2011), where he excelled in Hematology and Immunohematology. Additionally, Dia is pursuing certification as an International Medical Lab Technologist in Hematology (ASCPi) from the American Society for Clinical Pathology (2022-2025). His academic and professional development demonstrates a strong foundation in biomedical sciences, preparing him to make significant contributions to immunology research and clinical diagnostics.

Experience:

Dia Alfaki has worked as a Molecular Lab Technologist at G42 Healthcare (Biogenix Molecular Labs) from 2020-2023, contributing to advanced molecular research and diagnostics. His expertise spans a wide range of laboratory techniques, particularly in immunology, molecular biology, and hematology. Throughout his career, Dia has been involved in various research projects, including his Master’s thesis focused on the immune response to Plasmodium falciparum infection. He has also contributed to several high-impact publications, collaborating with experts in the field of malaria, immune phagocytosis, and cancer immunology. His role in molecular diagnostics has allowed him to apply his research findings to real-world clinical settings, furthering the understanding of disease pathology and therapeutic interventions.

Awards and Honors:

Dia Alfaki has been recognized for his significant contributions to biomedical science, particularly in immunology research. He participated in prominent international conferences, including the 6th European Congress of Immunology (2022) and the American Association for Cancer Research Annual Meeting (2021). His ongoing work in malaria immunology and cancer immunology is highly regarded in scientific communities. As a PG Member of the British Society of Immunology since 2021, Dia continues to gain recognition for his research on immune responses and inflammation. His work has also been highlighted in various prestigious journals, where his research on malaria and immune responses has earned accolades. These honors reflect his commitment to advancing scientific knowledge and improving healthcare through rigorous research.

Research Focus:

Dia Alfaki’s research is primarily focused on immunity, inflammation, cancer immunology, and molecular oncology. His work emphasizes understanding disease mechanisms, particularly the immune responses involved in infections like malaria and the pathogenesis of diseases such as cancer. Dia is particularly interested in the role of immune mediators, phagocytosis, and molecular interactions in disease progression and therapy. His research aims to explore therapeutic perspectives in immunology, using molecular and cellular approaches to better understand disease complexities and improve treatment options. His publications highlight these areas, especially in the context of malaria and inflammatory immune responses. Dia is also committed to utilizing molecular techniques and bioinformatics tools to contribute to new therapeutic strategies for immunological diseases.

Publications Top Notes:

  1. Patterns of Mannose-Binding Lectin (MBL) responses to Plasmodium falciparum infections in hyperendemic settings 📚🔬
  2. Inflammatory immune mediators and Plasmodium falciparum infection: a cross-sectional study among Sudanese patients with severe and uncomplicated malaria 🌍🦠
  3. Monocytes to lymphocytes ratio in peripheral blood and immunoglobulin IgE levels as indicators to Plasmodium falciparum infection in Sudan 📖🔬
  4. The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy 🦠🔬
  5. Plasmodium falciparum and immune phagocytosis: characterization of the process 🦠💉

Conclusion:

Dia Alfaki is an outstanding researcher with a well-rounded background in biomedical sciences, molecular biology, and immunology. His research accomplishments, publications, and contributions to international conferences highlight his drive for advancing scientific knowledge, particularly in the area of disease mechanisms and immune responses. His strong academic foundation, coupled with his practical lab experience and active engagement with the scientific community, positions him as an excellent candidate for the Research for Best Researcher Award. With a few areas of growth in clinical practice and cross-disciplinary collaborations, he has the potential to become a leader in global biomedical research.

Isabelle Brigaud | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Mrs. Isabelle Brigaud | Immunology Cellular Interactions | Best Researcher Award

Mrs. Isabelle Brigaud , CNRS IS2M , France

Isabelle Brigaud is an experienced research engineer at CNRS IS2M, Mulhouse, France. With a strong foundation in molecular biology, biochemistry, cell biology, and bioinformatics, she specializes in the study of biomaterials, tissue engineering, and immunology. Brigaud has made significant contributions to understanding the foreign body response to materials such as silicone breast implants and injectable hydrogels. Her expertise spans molecular cloning, protein analysis, and the development of study models using ex vivo, animal models (e.g., zebrafish, Drosophila, and Spodoptera littoralis), and advanced imaging techniques like confocal microscopy. Passionate about collaborative research, she is involved in managing cross-functional projects, fundraising, and mentoring students. Brigaud holds CNU qualifications in cell biology and physiology and is an advocate for continuous technical training. Her research has resulted in numerous high-impact publications in the field of biomaterials and molecular biology.

Publication Profile:

Orcid

Strengths for the Award:

  1. Diverse and High-Impact Research Focus: Isabelle Brigaud’s research spans multiple biological disciplines, including molecular biology, biochemistry, cell biology, and biophysics, showing a broad and in-depth understanding of biological processes. This is particularly demonstrated through her contributions to studies in immunogenic responses in breast implant tissue, the molecular mechanisms of endometriosis, and cellular interactions with biomaterials, indicating her versatility in tackling diverse biological challenges.
  2. Strong Publication Record: Brigaud has a consistent publication history in high-impact journals, such as Biomaterials, Nature Communications, Acta Biomater, and PRS. These publications focus on important topics like cellular migration, biomaterial interaction, and regenerative medicine, all of which are at the forefront of current biomedical research. Her work on the interaction of biomaterials with tissues, especially focusing on inflammatory responses, positions her as a leading researcher in the field.
  3. Expertise in Advanced Techniques: She is proficient in a wide range of cutting-edge techniques, from molecular biology techniques like RNAseq and PCR to cell biology methods, including cell differentiation and functional pharmacology. This technical expertise is key for producing reliable, reproducible results, which is crucial for advancing scientific knowledge.
  4. Cross-Disciplinary Collaboration: Brigaud’s experience in collaborating across various research teams, institutions, and international boundaries highlights her ability to contribute effectively to multidisciplinary research projects. She has also demonstrated leadership in supervising and training students and researchers, underscoring her role as a mentor and leader in the research community.
  5. Management and Funding Expertise: As a research engineer and project manager, she has led several important projects, such as those related to soft tissue reactions to implants and muscle regeneration. Her experience in fundraising and project management indicates strong organizational and leadership skills, both of which are crucial for steering complex research initiatives toward success.
  6. Commitment to Health-Related Research: Her work on health-related issues, such as the effects of silicone breast implants on immune responses and the management of endometriosis symptoms through exercise, shows a direct impact on improving human health. Her research addresses real-world health challenges, making it highly relevant and applicable to clinical settings.

Areas for Improvement:

  1. Broader Dissemination of Findings: While Brigaud has an impressive publication record, there is a potential for more dissemination of her findings to the broader scientific community, especially through high-visibility conferences and workshops. Increased visibility could attract more collaborative opportunities and funding for her projects.
  2. Expanding Research Focus on Novel Therapeutic Applications: Brigaud’s research has already significantly contributed to understanding biomaterials and cell interactions. Further expansion into therapeutic applications, such as designing and testing novel drug delivery systems or regenerative therapies, could strengthen her profile as a researcher with direct clinical and pharmaceutical applications.
  3. Increased Focus on Large-Scale Collaborative Projects: While Brigaud has demonstrated leadership in individual projects, engaging in larger, multi-institutional collaborative projects could provide even more resources and amplify the impact of her research on a global scale.
  4. Enhancing Outreach to Broader Audiences: Given her expertise in addressing important clinical and biomedical issues, there may be an opportunity for Brigaud to engage with broader non-specialist audiences, including through public science communication platforms, to make her work more accessible to the general public.

Education:

Isabelle Brigaud holds a PhD in Molecular Biology and Insect Physiology from Jussieu, Paris VI, awarded with first-class honors in 2008. She also completed a Master 2 in Integrative Biology and Physiology, specializing in adaptation to the environment, and a Master 1 in Population and Ecosystem Biology and Ecophysiology, both from Jussieu, Paris VI, with honors. Brigaud has expanded her academic credentials with postdoctoral research experiences at the University of Freiburg, Germany (2012-2014), focusing on the cytoskeleton organization in zebrafish development. Prior to that, she conducted research at CNRS/INSERM in Lyon, France (2009-2011), where she studied the plasticity of cell morphology during Drosophila oogenesis. Her academic journey reflects a deep commitment to understanding molecular biology, cell biology, and biochemistry, which has shaped her research trajectory and expertise in biomaterials and tissue engineering.

Experience:

Isabelle Brigaud has extensive experience in molecular biology, cell biology, and biochemistry. She has worked at CNRS IS2M, Mulhouse, France, since 2019 as a research engineer, managing biomolecule platforms and leading studies on the foreign body response to silicone implants and injectable hydrogels. Brigaud previously held postdoctoral research positions at the University of Freiburg, Germany, and CNRS/INSERM, Lyon, France, where she investigated cytoskeletal dynamics in zebrafish lateral line development and cell morphology plasticity during Drosophila oogenesis. During her PhD at INRAE, Versailles, she focused on pheromone detection mechanisms in pest moths, an experience that formed her expertise in molecular biology and insect physiology. In addition to her hands-on research, Brigaud is involved in cross-functional project management, collaborative teamwork, and student supervision, demonstrating strong leadership skills and a passion for advancing scientific knowledge.

Awards and Honors:

Isabelle Brigaud’s work has been recognized through several prestigious publications and her contributions to the fields of biomaterials and molecular biology. Her research on the foreign body response to silicone breast implants and injectable hydrogels has made significant strides in understanding tissue regeneration and inflammatory responses. As an active member of the research community, she has been involved in multiple high-impact journal articles published in prominent scientific journals such as Biomaterials, Acta Biomaterialia, and Nature Communications. Although specific awards are not detailed in her profile, her extensive publication record, including multiple first-author and co-author contributions, highlights her ongoing influence in the scientific community. Brigaud’s commitment to advancing knowledge in biomaterials, molecular biology, and tissue engineering is further demonstrated through her leadership roles in cross-disciplinary projects, mentoring students, and managing research collaborations.

Research Focus:

Isabelle Brigaud’s research focuses on the intersection of molecular biology, biomaterials, and tissue engineering, with a specific interest in understanding the foreign body response to implants and regenerative therapies. Her work explores the immune reactions induced by materials like silicone breast implants and injectable hydrogels, aiming to improve tissue regeneration and reduce inflammation. Brigaud’s expertise includes molecular cloning, protein analysis, cell culture, and advanced imaging techniques, all of which she applies to study cell behavior, tissue interactions, and the effects of materials on cellular processes. She uses animal models, including zebrafish and Drosophila, to investigate cell morphology plasticity and mechanotransduction. Her focus also extends to the development of drug delivery systems and the role of extracellular matrix in inflammation and tissue healing. Brigaud’s collaborative approach to research has led to significant advances in the study of immunology, regenerative medicine, and biomaterials.

Publications Top Notes:

  • Brigaud I et al., 2024. Breast implant silicone exposure induces immunogenic response and autoimmune markers in human periprosthetic tissues. Biomaterials 🔬💉
  • Ouedraogo C et al., 2024. Fabrication and characterization of thin self-rolling film for anti-inflammatory drug delivery. Colloids Surf B Biointerfaces 💊🧬
  • Escriva-Boulley G et al., 2023. Effects of physical activity and endometriosis-based education program delivered by videoconference on endometriosis symptoms: the CRESCENDO program. Trials 🏃‍♀️🩺
  • Brigaud I et al., 2020. Surface texturization of breast implants impacts extracellular matrix and inflammatory gene expression in asymptomatic capsules. PRS 🦠🔬
  • Wakhloo NT et al., 2019. Actomyosin, vimentin and LINC complex pull on osteosarcoma nuclei to deform on micropillar topography. Biomaterials 🦴🔬
  • Pieuchot L et al. 2018. Curvotaxis directs cell migration through cell-scale curvature landscapes. Nature Commun. 🌍🧬
  • Brigaud I et al. 2017. Synergistic effects of BMP-2, BMP-6 or BMP-7 with human plasma fibronectin onto hydroxyapatite coatings: A comparative study. Acta Biomater. 🧫
  • Brigaud I et al., 2015. TGFbeta/activin signaling induces epithelial cell flattening during Drosophila oogenesis. Biol Open 🦗💡
  • Montagné N et al., 2012. Functional characterization of a sex pheromone receptor in the pest moth Spodoptera littoralis by heterologous expression in Drosophila. European Journal of Neuroscience 🦋👃
  • Montagne N et al.,2011. Functional characterization of a sex pheromone receptor in the pest moth Spodoptera littoralis. Chemical Senses 🦋💨
  • Brigaud I et al., 2009. Identification of an atypical insect olfactory receptor subtype highly conserved within noctuids. FEBS Journal 🦗👃
  • Brigaud I et al. 2009. Cloning and expression pattern of a putative octopamine/tyramine receptor in antennae of the noctuid moth Mamestra brassicae. Cell and Tissue Research 🦋🧬

Conclusion:

Isabelle Brigaud is undoubtedly a strong contender for the Research for Best Researcher Award. Her multifaceted expertise, robust publication record, and impactful contributions to molecular biology, cell biology, and biochemistry, particularly in the context of health applications, position her as a leader in her field. With her proven ability to manage large-scale research projects and mentor the next generation of scientists, she continues to make significant strides in biomedical research. By focusing on increasing the visibility of her findings and expanding her research into therapeutic domains, Brigaud could further elevate her already outstanding career.